David Young - Jun 23, 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jun 23, 2021
Transactions value $
$76,716
Form type
4
Date filed
6/23/2021, 05:12 PM
Previous filing
Jun 10, 2021
Next filing
Jul 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $76.7K +10K +2.98% $7.67* 345K Jun 23, 2021 Direct
holding PCSA Common Stock 549K Jun 23, 2021 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 689K Jun 23, 2021 By Family Entities
holding PCSA Common Stock 55.3K Jun 23, 2021 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.